Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Off-label use - only a matter of physicians` drug prescription?

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: NIEMANN, Dorothee (Department of Clinical Pharmacy, Institute of Pharmacy, University of Leipzig, Department of Clinical Pharmacy, Leipzig, Germany)
  • Co-author(s): Meyrath, D. (Department of Clinical Pharmacology, University Hospital Heidelberg, Heidelberg, Germany)
    Oelsner, S. (Department of Clinical Pharmacology, University Hospital Heidelberg, Heidelberg, Germany)
    Ewen, A.L. (Department of Clinical Pharmacology, University Hospital Heidelberg, Heidelberg, Germany)
    Pickardt, B. (Department of Clinical Pharmacology, University Hospital Heidelberg, Heidelberg, Germany)
    Henhapl, T. (University Children's Hospital, University of Heidelberg, Heidelberg, Germany)
    Boehm, M. (University Children's Hospital, University of Heidelberg, Heidelberg, Germany)
    Ruef, P. (University Children's Hospital, University of Heidelberg, Heidelberg, Germany)
    Meyburg, J. (University Children's Hospital, University of Heidelberg, Heidelberg, Germany)
    Haefeli, W.E. (Department of Clinical Pharmacology, University Hospital Heidelberg, Heidelberg, Germany)
    Bertsche, T. (Department of Clinical Pharmacy, Institute of Pharmacy, University of Leipzig, Leipzig, Germany)
  • Abstract:

    I. BackgroundOff-label use in children is common and may lead to drug-related problems (DRP). However, not only deviations from the labelled (contra-)indications, dosage schemes, or age ranges but also deviations from labelled administration processes are considered off-label use.II. AimWe aimed to assess the prevalence of off-label paediatric

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses